Form C Passu, Inc.
- Wall Street ends sharply lower in broad sell-off
- China Property Titan Evergrande (EGRNF) Collapses to 11-Year Lows, Analysts Wary of Domino Effect
- Apple (AAPL) iPhone 13 Has Strong Start with Positive Mix Skew - JP Morgan
- Lennar (LEN) Falls as Reported Q3 Revenue Beats, EPS Slightly Missed Estimates
- Royal Dutch Shell to Sell its Permian Business to ConocoPhillips (COP) for $9.5 Billion Cash
Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.
C 0001865457 XXXXXXXX LIVE false false false Passu, Inc. Corporation DE 03-23-2017 1370 NORTH SAINT ANDREWS PLACE LOS ANGELES CA 90028 https://www.dims.world/ N OpenDeal Portal LLC 0001751525 007-00167 283874 At the conclusion of the offering, the issuer shall pay a fee of six percent (6%) of the amount raised in the offering to the Intermediary. The Intermediary will also receive compensation in the form of securities equal to two percent (2%) of the total number of the securities sold in the offering. Other Crowd SAFE (Simple Agreement for Future Equity) 25000 1.00000 Arbitrary 25000.00 Y Other At the Intermediary's discretion 1070000.00 11-30-2021 7.00 557605.00 218526.00 158727.00 60443.00 2067.00 1082.00 628121.00 372461.00 850665.00 65000.00 2190282.00 141221.00 1271817.00 149602.00 0.00 0.00 -789494.00 -434416.00 AL AK AZ AR CA CO CT DE DC FL GA HI ID IL IN IA KS KY LA ME MD MA MI MN MS MO MT NE NV NH NJ NM NY NC ND OH OK OR PA PR RI SC SD TN TX UT VT VA WA WV WI WY Passu, Inc. Eugene Kim CEO Eugene Kim CEO 06-17-2021
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Poxel Completes Enrollment in Phase 2 NASH Trial for PXL065 (DESTINY-1) in Biopsy-Proven Patients
- Viridian Therapeutics Announces Pricing of Public Offering of Shares of Common Stock and Preferred Stock
- New Dupixent® (dupilumab) data in patients as young as 6 years old with moderate-to-severe atopic dermatitis to be presented at WCPD and EADV
Create E-mail Alert Related CategoriesSEC Filings
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!